ArticleCellular and molecular life sciences : CMLS2026
ZFP91 restricts RSV replication by driving K48-linked ubiquitination and proteasomal degradation of M2-1.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children. Among viral components, the M2-1 protein is essential for efficient transcription and replication. Given its pivotal role in the viral life cycle, host factors that regulate this process may represent potential therapeutic targets against RSV. In this study, we identified the E3 ubiquitin ligase ZFP91 as a host factor that restricts RSV replication. Notably, RSV infection upregulated ZFP91 expression; ZFP91 overexpression significantly suppressed viral replication, whereas ZFP91 knockdown increased viral titers and viral gene expression, including that of M2-1 and N. Importantly, in an RSV-infected mouse model, epithelial-specific loss of ZFP91 increased viral burden and M2-1 protein levels in lung tissues, confirming its antiviral function in vivo. Mechanistically, ZFP91 directly interacted with M2-1 and promoted its degradation by catalyzing K48-linked polyubiquitination at lysine residues 8, 48, and 52. Collectively, these findings identify ZFP91 as a key regulator of RSV replication and reveal a novel antiviral mechanism mediated by its E3 ubiquitin ligase activity. This work thus provides new insights into RSV pathogenesis and host-virus interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.